Judge Profile

Neil T. Powell

123 IP cases indexed. Covers patent matters.

Cases Presided Over

123 cases indexed | Page 3 of 5

patent denied · Aug 22, 2024

Hulu, LLC et al. v.Piranha Media Distribution, LLC

· IPR2024-01253

The PTAB denied Hulu’s petition to institute inter partes review of Piranha Media’s eSports patent, finding the petition failed the compelling merits standard. No claims were instituted or found unpatentable.

patent denied · Aug 22, 2024

Hulu, LLC et al. v.Piranha Media Distribution, LLC

· IPR2024-01252

The PTAB denied Hulu’s petition to institute an IPR against Piranha Media’s eSports platform patent, citing the patent’s prior invalidation in district court. The Board exercised its §314(a) discretion, concluding that proceeding would be inefficient.

patent denied · Aug 22, 2024

Hulu, LLC et al. v.Piranha Media Distribution, LLC

· IPR2024-01252

The PTAB denied Hulu’s petition to institute an IPR against a peer‑to‑peer gaming patent, finding the petition failed the compelling‑merits test. The Board concluded the cited prior art did not teach key claim limitations, resulting in a discretionary denial under § 314(a).

patent terminated or settled · Aug 15, 2024

Bitsgap Holding OU et al. v.Intercurrency Software LLC

· IPR2024-01293

Bitsgap Holding and related crypto‑trading entities settled their dispute with Intercurrency Software, resulting in the Board terminating four IPRs before trial. The settlement agreement was kept confidential per 37 C.F.R. § 42.74(c).

patent terminated or settled · Aug 15, 2024

Bitsgap Holding OU et al. v.Intercurrency Software LLC

· IPR2024-01292

Bitsgap Holding OU and related crypto firms settled with Intercurrency Software LLC, filing an unopposed motion to withdraw their IPR petitions. The PTAB granted the motion and terminated the proceedings, treating the settlement agreement as confidential.

patent all challenged claims unpatentable · Jul 19, 2024

3D Diagnostix, Inc. v.Watson Guide IP, LLC

· PGR2024-00040

The PTAB found that all challenged claims were obvious over various combinations of prior art references, including Llop '126 and Sichuan. The Board determined there was a clear motivation for a person skilled in the art to combine these references to achieve the claimed invention.

patent terminated or settled · Jul 2, 2024

Tempur Sealy International, Inc. et al. v.Purple Innovation, LLC

· IPR2024-00482

Tempur Sealy and Purple Innovation reached a confidential settlement, leading the PTAB to dismiss the IPR before it was instituted.

patent all challenged claims upheld · Jun 28, 2024

Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.

· PGR2024-00039

Samsung’s post‑grant review of Oura’s smart‑ring patent (U.S. 11,874,702) was denied. The Board held that none of the 17 claims were obvious over the cited prior art, affirming the patent’s validity.

patent instituted · Jun 28, 2024

Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.

· PGR2024-00039

Samsung Electronics successfully petitioned to challenge Ouraring's patent (11874702) in a PGR proceeding, leading the PTAB to grant institution. The Board determined that the challenges based on prior art met the institutional threshold for trial.

patent denied · Jun 28, 2024

Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.

· PGR2024-00038

The PTAB denied a Post-Grant Review filed by Samsung against Oura Health's patent '701 because the Patent Owner had disclaimed all challenged claims.

patent instituted · Jun 28, 2024

Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.

· IPR2024-01078

The PTAB granted institution for a high-stakes IPR concerning wearable biosensor technology, specifically smart rings. The Board found sufficient evidence of obviousness (103) and anticipation (102) to proceed with trial on 17 claims.

patent denied · Jun 28, 2024

Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.

· IPR2024-01080

The PTAB denied an IPR petition filed by Samsung against Oura Health because the patent owner had disclaimed all challenged claims.

patent denied · Jun 28, 2024

Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.

· IPR2024-01079

The PTAB denied an IPR petition filed by Samsung against Oura Health because the patent owner had disclaimed all challenged claims. This denial was based on procedural rules regarding pre-institution claim disclaimer.

patent instituted · Jun 28, 2024

Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.

· IPR2024-01077

Samsung Electronics successfully pushed through the institution phase of its IPR challenge against Oura Health's '859 Patent. The Board found that the second challenge, based on prior art including Schröder and Mestas, met the threshold for obviousness (103).

patent final · Jun 28, 2024

Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.

· IPR2024-01078

The Board upheld the validity of Oura Health's smart ring patent against Samsung Electronics in a Final Written Decision. The Panel found that the Petitioner failed to demonstrate obviousness over prior art combining physical activity monitoring and wearable input devices.

patent final · Jun 28, 2024

Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.

· IPR2024-01077

The PTAB issued a Final Written Decision rejecting all grounds of obviousness (35 U.S.C. § 103) against the smart ring patent. The Board upheld the validity of the claims, finding that the combination of prior art references required non-obvious structural overhauls and lacked proper nexus to the claimed invention.

patent instituted · Jun 12, 2024

ResMed Corp. v.Cleveland Medical Devices, Inc.

· IPR2025-00160

The PTAB granted institution for ResMed Corp.'s IPR against Cleveland Medical Devices, Inc., finding a reasonable likelihood of prevailing. The Board overcame arguments regarding parallel District Court litigation by applying the Fintiv factors.

patent instituted · Jun 12, 2024

ResMed Corp. v.Cleveland Medical Devices, Inc.

· IPR2025-00159

ResMed Corp. successfully petitioned for institution of its IPR against Cleveland Medical Devices, Inc.'s patent covering CPAP systems. The Board declined discretionary denial, finding that the petitioner adequately demonstrated a reasonable likelihood of prevailing on both 102 and 103 grounds.

patent instituted · Jun 12, 2024

ResMed Corp. v.Cleveland Medical Devices, Inc.

· IPR2025-00158

ResMed Corp. successfully convinced the PTAB to institute IPR proceedings against Cleveland Medical Devices, Inc.'s patent (No. 11690512). The Board found that ResMed demonstrated a reasonable likelihood of prevailing on Ground 1, allowing the challenge to proceed despite neutral merits.

patent denied · May 31, 2024

Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.

· PGR2024-00031

The PTAB denied Samsung's Post-Grant Review petition against Ouraing because the patent owner had statutorily disclaimed all 16 challenged claims.

patent instituted · May 31, 2024

Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.

· PGR2024-00030

Samsung Electronics successfully petitioned to challenge Oura Health's patent (11868178) in a PGR proceeding, leading the PTAB to institute the case. The Board found Petitioner's arguments regarding prior art disclosures for battery and PCB placement sufficient to proceed to trial.

patent denied · May 31, 2024

Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.

· IPR2024-00930

The PTAB denied Samsung's IPR petition against Oura Health because the patent owner had statutorily disclaimed all challenged claims.

patent denied · May 31, 2024

Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.

· IPR2024-00929

The PTAB denied institution of an IPR filed by Samsung against Oura Health because the patent owner had formally disclaimed all 12 challenged claims.

patent instituted · May 31, 2024

Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.

· IPR2024-00928

The PTAB granted institution of IPR for Samsung against Oura Health regarding the 'Wearable Computing Device' patent (9582034). The Board found a reasonable likelihood that Samsung would prevail on grounds of obviousness over LeBoeuf.

patent mixed - some claims cancelled, some upheld · May 31, 2024

Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.

· PGR2024-00030

Samsung Electronics challenged Oura Health's patent claims in a PGR proceeding, arguing obviousness and anticipation. The PTAB found the vast majority of the grounds unpersuasive, but ultimately cancelled two dependent claims (17 and 18) under § 112(d).

patent final · May 31, 2024

Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.

· IPR2024-00928

The PTAB found that several claims related to finger-worn monitoring devices were unpatentable over prior art combinations. The Board adopted a narrow claim construction for 'substantially transparent external potting,' which aided the Petitioner's argument of obviousness.

patent terminated or settled · May 29, 2024

Google LLC et al. v.EyesMatch Ltd.

· IPR2024-00856

Samsung filed a joint motion to terminate the IPR after reaching a settlement with EyesMatch. The Board granted the motion and sealed the settlement agreement, ending Samsung's participation in the proceeding.

patent terminated or settled · May 29, 2024

Google LLC et al. v.EyesMatch Ltd.

· IPR2024-00856

Google, Samsung, and Microsoft settled their IPR challenge to EyesMatch’s ’109 patent. The Board granted a joint motion to terminate the proceeding and sealed the settlement agreement.

patent instituted · May 29, 2024

Google LLC et al. v.EyesMatch Ltd.

· IPR2024-00856

Google LLC et al. successfully petitioned for institution of IPR against EyesMatch Ltd.'s patent 8982109, challenging claims based on obviousness (35 U.S.C. § 103). The Board declined to deny institution despite arguments regarding parallel district court litigation.

patent Final Written Decision · May 29, 2024

Google LLC et al. v.EyesMatch Ltd.

· IPR2024-00856

The PTAB issued a Final Written Decision rejecting all claims (1-18) because the Petitioner failed to demonstrate unpatentability by a preponderance of the evidence. The Board adopted a nuanced claim construction from District Court, requiring specific elements like reversed reflection and double distance for 'mirror mimicking.'

Arctic Invent — IP Strategy

Facing a similar IP matter?

Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.

Consult our team →